Clinical Trials Logo

Breast Neoplasms clinical trials

View clinical trials related to Breast Neoplasms.

Filter by:

NCT ID: NCT02964234 Completed - Breast Diseases Clinical Trials

Empowering Latinas to Obtain Breast Cancer Screenings

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

The participatory-based project will quantify the 'added benefit' of an empowerment intervention relative to an education intervention for 150 Latinas on the following outcomes: women's adherence to breast cancer screening guidelines; women's psychosocial facilitators (self-efficacy, norms, support, and knowledge); and women's dissemination of breast health messages throughout their social network. The empowerment intervention will train Latinas in how to discuss breast health with their family and friends and volunteer in local breast health promotion programs. Academic, clinician, and community partners will work together throughout intervention development and evaluation.

NCT ID: NCT02963740 Completed - Clinical trials for Breast Cancer Female

Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer Survivors

Start date: November 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to demonstrate that breast cancer survivors who need to lose weight are able to follow a weight loss program which combines modest calorie restriction with a graduated activity program..

NCT ID: NCT02961790 Completed - Breast Carcinoma Clinical Trials

Oxybutynin Chloride in Managing Hot Flashes

Start date: December 9, 2016
Phase: Phase 3
Study type: Interventional

This randomized phase III trial studies how well oxybutynin chloride works in managing hot flashes in patients who are not candidates for, or not interested in hormone replacement therapy. Previous studies have shown that oxybutynin is effective in managing hot flashes, however doses used in prior studies have resulted in side effects. This trial is evaluating lower doses of oxybutynin with the goal of determining if they are efficacious with less side effects. ADAM-VTE

NCT ID: NCT02958449 Completed - Cancer, Breast Clinical Trials

Prospective Clinical Investigation Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques With TissuGlu® and No Drains (Test) in Mastectomy

Start date: December 2016
Phase: N/A
Study type: Interventional

Comparing standard wound closure technique with drains (control) to standard wound closure techniques with TissuGlu® and no drains (test) in mastectomy

NCT ID: NCT02958332 Completed - Lymphedema Clinical Trials

Effects of a Videogame-based Program on Women With Lymphedema Secondary to Breast Cancer

Start date: November 2016
Phase: N/A
Study type: Interventional

Aims: To demonstrate the effect of a program based on video games as a means to improve abilities and basic skills affected by lymphedema, and its impact on quality of life. Design: longitudinal, pre-experimental, with pre / post-test and evaluation, assessor blinded study. Method: Data on shoulder pain and disability, health-related quality of life, strength and articulate activated by the OSS (Oxford Shoulder Score), SPADI (Shoulder Pain and Disability Index), FACT-B + 4 (Functional Assesment of Cancer Therapy Questionnaire for Breast Cancer), respectively goniometry and dynamometry amplitude scales will be collected. The intervention will be performed with the Wii ™ console and the Wii Balance BoardTM, during 5 individual weekly sessions of 30 minutes.

NCT ID: NCT02957981 Completed - Pancreatic Cancer Clinical Trials

The Genetic Education for Men Trial: Web-Based Education vs. Standard Care

GEM
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

The primary goal of this research is to develop and test a web-based genetic education/counseling intervention. This intervention is designed to educate men from hereditary cancer families about the personal relevance of genetic testing in order to help them make decisions about whether to pursue genetic testing. The investigators will test this intervention against standard care for men from hereditary cancer families. The web-based educational intervention includes all of the information typically covered during genetic counseling. As a result, after completing the education intervention participants can proceed directly to genetic testing if they choose. The investigators will conduct a survey prior to randomization and then follow-up surveys at 1-month and 6-months post-randomization. The primary outcome will be uptake of genetic testing. Secondary outcomes will be completion of genetic counseling and decision satisfaction.

NCT ID: NCT02957526 Completed - Clinical trials for Breast Neoplasm Female

Web-Base App To Improve Aromatase Inhibitor Adherence

AETAPP
Start date: December 2015
Phase: N/A
Study type: Interventional

The purpose of this study will be to test the use of a web-based mobile application (app) initiated at the time of the initial prescription to an aromatase inhibitor to improve communication and management of treatment-related adverse symptoms among patients with hormone-receptor positive breast cancer.

NCT ID: NCT02956473 Completed - Breast Cancer Clinical Trials

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy

Start date: November 15, 2016
Phase: N/A
Study type: Interventional

This research study involves the use of a common breast imaging modality (magnetic resonance imaging, 'MRI') and is investigating its role in evaluating surgical decision making for breast cancer when it is performed with the patient in a new position (lying on one's back) as opposed to in the standard position (lying on one's stomach).

NCT ID: NCT02954900 Completed - Breast Neoplasms Clinical Trials

Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study

KYRAS
Start date: March 15, 2016
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer chemoprevention. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care setting. The investigator hypothesizes that improving accuracy of breast cancer risk perception and understanding of the risks/benefits of chemoprevention will enhance informed decision-making and uptake of breast cancer prevention strategies in the primary care setting.

NCT ID: NCT02954471 Completed - Breast Cancer Clinical Trials

Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia

Start date: October 21, 2016
Phase:
Study type: Observational

This is a retrospective, multicenter study, consisting of chart review of Saudi Arabian participants diagnosed with breast cancer between 2007 and 2013 and with available human epidermal growth factor receptor 2 (HER2) testing. Data on survival will be collected through 2015.